Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Hamlet BioPharma

5.91 SEK

+1.20 %

Less than 1K followers

HAMLET B

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hamlet BioPharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-17.1-22.8-7.5-17.1-20.0-32.9-44.7
EBIT-17.1-22.9-7.5-17.1-20.0-40.5-53.1
Profit before taxes-17.1-23.4-7.7-17.2-19.9-39.8-52.7
Net income-17.1-23.4-7.7-17.2-19.9-39.8-52.7
EPS-0.17-0.22-0.07-0.15-0.17-0.24-0.30
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-213.0 %-223.7 %-280.4 %-45.3 %-93.0 %-59.5 %-129.0 %
ROI-151.5 %-161.0 %-60.6 %-41.2 %-68.8 %-56.0 %-109.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.